On July 10, 2022, the Rosen Law Firm, a prominent global investor rights firm, alerted shareholders of DENTSPLY SIRONA Inc. (NASDAQ: XRAY) about the impending deadline for participation in a class action lawsuit. This action is focused on individuals who purchased DENTSPLY stock between June 9, 2021, and May 9, 2022. Investors must be aware that they have until August 1, 2022, to apply as lead plaintiffs in the ongoing case.

If you acquired DENTSPLY shares during this period, you may qualify for compensation without any upfront costs, as the firm operates on a contingency fee basis. Interested investors can join the class action by visiting Rosen Legal’s submission form or by contacting Phillip Kim, Esq., toll-free at 866-767-3653 or via email at [email protected].

The class action lawsuit claims that DENTSPLY and its executives made misleading statements regarding the company’s financial health. Specifically, it alleges that they manipulated accounting practices related to a distributor rebate program, misleading investors and inflating the company’s revenue and earnings. Consequently, DENTSPLY’s financial statements did not comply with Generally Accepted Accounting Principles (GAAP) and Securities and Exchange Commission (SEC) regulations, which led to artificially inflated stock prices. The lawsuit contends that investors faced significant losses once the truth about the company’s financial practices was revealed.

The Rosen Law Firm encourages investors to choose experienced legal counsel with a successful track record in securities class actions. Unlike many firms that simply act as intermediaries, Rosen Law Firm specializes in securities litigation, boasting a history of substantial settlements for investors, including the largest securities class action settlement against a Chinese company. The firm consistently ranks highly in securities class action settlements and has secured hundreds of millions of dollars for its clients over the years.

For more information about this case and the opportunity to participate, investors are urged to reach out to the Rosen Law Firm promptly.